Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PRK | corrigan, where to now ?? | 12/05/06 | 1 | 884 | |||
|
|||||||
PRK | resginations | 12/05/06 | 0 | 432 | |||
|
|||||||
PRK | major accumulation | 11/05/06 | 1 | 756 | |||
|
|||||||
PRK | huge bid! | 11/05/06 | 1 | 741 | |||
|
|||||||
PRK | what's the story?? | 10/05/06 | 1 | 679 | |||
|
|||||||
PRK | help out here! | 10/05/06 | 0 | 410 | |||
|
|||||||
PRK | mbl pulls out - prk | 09/05/06 | 4 | 1.1K | |||
|
|||||||
PRK | any ideas?? | 09/05/06 | 2 | 1.2K | |||
|
See All Discussions